BSECompany Update1d ago · 27 Oct 2026, 01:09 pm

Newspaper Advertisment - Unaudited Fianncial Results of the Company for Q2 & H1 FY27

Mankind Pharma Ltd · 543904

✦ AI Summary▲ PositiveResults

Mankind Pharma Ltd has announced unaudited financial results for the quarter and half year ended September 30, 2026. The company reported revenue from operations of ₹4,337.86 crore, profit for the period/year before exceptional items and tax of ₹929.11 crore, and profit for the period/year after exceptional items and tax of ₹716.12 crore. The company also declared an income distribution cum capital withdrawal of ₹17.23 per equity share.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment9/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Mankind Pharma Ltd - 543904 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Attachments (1)

📄

00161675-eaed-4927-af97-d918a05ec4d7.pdf

pdf

Download →
View document text
Mankind/II,._ October 27, 2026 BSE Limited National Stock Exchange of India Limited P J Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Scrip Code: 543904 Symbol: MANKIND Dear Sir/ Madam, Subject: Newspaper Advertisement - Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2026 Ref: Regulations 30, 47 and 52(8) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 Please find enclosed herewith copies of the newspaper advertisement of the Unaudited Financial Results of the Company for the quarter and half year ended on September 30, 2026 as published in “Financial Express” and "Jansatta" on October 27, 2026. You are requested to kindly take the above information on your records. Thanking You, Yours Faithfully, For Mankind Pharma Limited Hitesh Kumar Jain Company Secretary & Compliance Officer Encl.: A/a MANKIND PHARMA LIMITED Regd. Office: 208, Okhla Ind. Estate, Phase -3, New Delhi-110020 •Ph.: 011-46846700, 47476600 CIN No. L74899DL 1991 PLC044843 •E-mail: contact@mankindpharma.com • www.mankindpharma.com PUSHPSONS INDUSTRIES LIMITED Regd. Offlc-,e.: 8--40. Okhla lndustrtel Area, Phase -t MANKIND PHARMA LIMITED Corporate Office, Chennai. ���������������������������� Tel: +9·1-11-41610121 Fax: +91·11-'10S8461 Registered Office: 208, Okhla Industrial Estate. Phase-Ill, New Delhi -110 020, Delhi, India; Tel.: +91 1147476600 ��� ��������� ��� ������ Email id: info@pushpsons.com Indian Bank, a leading Public Sector Bank, has floated ����������������������� Website: www.pushpsons.com following RFPs. Corporate Office: 262, Okhla Industrial Estate, Phase-Ill, New Delhi - 110 020. Delhi, India; Tel.: +91 11 4684 6700 NOTICE Email: investors@mankindpharma.com, Website: www.mankindpharma.com, CIN: L74899DL 1991PLC044843 1) RFP for Procurement of Saas Security Information PtlrSIJanl lo Regulahon 29 read wilh Regt#.a!ion 47 ol SEBI (Usbng and Even! Management (SIEM) Plattorm ������������������������� EXTRACT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2026 Obli~tion and Disdosure Requiremenls) Reg1Jlation, 2015, nob is �������������������������� heteby gi<.'en lnat a meet11g of 8oa'rd Qi Oirec,ors is sched\lle!1 to be 2) RFP lor Procurement for Supply, Implementation ������������������������� hekl on Th111Sday, November 12., 2~26 al Nc,v Delhi, 11,tcr..atla to and Main1enanca of solution for generation and ~ in Crores except as staled otherwise) cor~e, and approve lhe Un-aud118d financial ros"'s (Slandaton&) of assessment ol Software Bill of Material (SBOM) & lhe CO!fi}any tor the half yea, and quarter ended Seplemher 30, 2026. C,yptographlc BIii ol Material (CBOM) for period of The said notice may be accessed on the Comp,any's website ai 3 (three) years For tho year l\ltp.llwww.pushpsons.com. also on Lhe website 01 the stock For the quarter ended For the si~ months enaed ���������������������� exchange at ht1p:flwww.bseindia.com. 3) RFP tor Supply, Implementation and Maintenance Particulars ended �� �������� ���� ��� ol Automated 1oollor IS audit and ITGRC No. For Pushpsons Industries Llmlted ������������������������� 30.09.2026 30.06.2026 30.09,.2025 30.09.2026 30.09.202S 31.03.2026 Sdl• Interested parties may refer Bank's Website: ������������� �� ��� Pankaj Jain hUps:llwv.ll'tt,indianbank,t>ank,inltenders/ & !.eM (Unaudited) (Unaudltedf (Unaudited) (Unaudited) (Unaudited) (Audited) Place: New Delhi Director ����������������� Date: October 26, 2026- DIN: 00001923 11.Q.t!mlor details, 1 Revenue from operations 4.337,86 4.030.59 3,697.16 8,369.45 7,267.51 14,277.64 2 Profit for the period/year before exceptional items and tax 929.11 769.45 624.02 1,698.56 1.164.51 2,462.43 •l!DJ· 3 Profit for the period/year after exceptional items and tax 716.12 574.09 520.18 1.290.21 964.80 1,938.10 4 Tolal comprehensive incom<? for the period/ year 715.27 553.78 543.09 1,269,05 986.95 1,995.14 UTI Mutual Fund 5 Paid up equity share capital 41.30 41.30 41.28 41.30 41.28 41.28 1/.,.'f, .,Jc. /,e,lo.f"~ zi11J.":,i 1-,,,. 6 Other equity excluding revaluation reserve N.A. N.A. N.A. N.A. N.A. 16,259.06 7 Earnings per equity share of lace value of~ 1 eacll Notice For Declaration of Income Distribution Cum Capital Withdrawal • Basic EPS (in (I 17.23 13.76 12.39 30.99 23.01 46.35 • Diluted EPS (in t) 17.20 13.74 12.38 30.94 22.98 46.28 Quantum of Face (Not (Not (Nol (Nol (Not Sr. IOCW(Gross Value NAV as on October 23. 2026 (per unit! No, Scheme Name Oi.strlbutabl~ Amt J• (Rs. per annualised) annualised) annualised) annualised) annualised) o/o Rs. oer unJt Plan/Ootlon Rs. The key standalone financial information is as under: I UTI Conse,vanve Hybrid Fund 7.00% 0.7000 Oiren P!an -Aex1P aypuc of rocw Opuon 48.8780 10 (' In Crores except as stated otheivAse) 2 UTI Conservaave H)'bod funa 7.00% 0,7000 Regular Plan • Flexi Pa>jOUt of IDCW Option 43.6476 3 UTI Muln Asser A!!ocanan funa 2.50% 0.2500 Direct Plan -Payout of IDCW Option 32.5827 For the year 10 For the quarter ended For the six months ended 4 U1 I MulN Asser AllocanQO Fund 2,50% 0.2500 Regular Plan -Payootof IDCW Option 27,6226 s. end~d s UTI Aflnresslve Hy!)lid Fvn<J 8.50% 0.8500 Direct Plan - Payout of IDCW Option 42,9379 Particulars 10 No. 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 I, UTI AggresSM-~l)rid F...,vt 8.50% 0.8500 Regvldr Plan -P.1y0l.ll of IDC\1/ Opuon 37,7478 7 ur, Balanced Aovantlge Fund 1.00% 0.2000 Direct Pid(I • Payour of IOCW Option 12.6156 (Unaudited) (Unaudttedl (Unaudited) (Unaudited) (Unaudited) (Audited I 8 UTI Balanced Advantage Fund 2.00% 0.2000 Re!)Ular Plan-Payout or IDCW opuon 12.0802 1 Revenue from operations 3,145.22 2,964.05 2,636.95 6,109.27 5,206.68 10,421.18 9 UTI EquflY Sa11ings Fund 2.00% 0.2000 Direct Plan -Ouat1e,1y Payout or IDCW Opt,on 19.9270 10 UTI Equ1(l/ Savings Fund 2.00% 02000 10 Regular Pklr\ • Ou~ce,1y rayaut or 1ocw Op11oro 18,4981 2 Profit tor the period/year before exceptional items and tax 783.59 756.57 525.53 1,540.16 1.021.70 2,421.24 11 UTI Large Cap Fund 15.00% I 5000 Direct Plan -Paya1,t or 1ocw Option 58.979,! 3 Profit lor the period/year afte, exceptional items and tax 581.95 558.49 459,80 1.140.44 87S.07 2,037.56 12 UTI Lart>e Cap Fund 15.00% I 5000 Regular Plan -Payout or IDCW <)prlon 49.3865 4 Tolal Cl>mprellensive income lor the period/year 588.67 552.49 475.59 1,141.1~ 891.92 2,066.17 Record date for all the above mentioned schemes/plans will be Thursday, October 29, 2026 *Disrribution of 5 Net worth (f Crores) 11.564.28 16.967.03 15,271.95 17,564.28 15,271.95 16,396.94 above IDCW 1s suqject to the availability of distribut<1ble surplus ,;son record date. Income distribution cum capital 6 Debt equity ratio (times) 0.26 0.25 0.48 0.26 0.48 0.34 wlthdra~val payment to the investo1 will be lower to the extent of statuto,y levy fif applicablef. Income dismbutlon will be made. ner of tax deducted at source as applrcable. 7 Debi service coverage ratio (times) 0.54 0.59 1.53 0.56 1.02 0.52 Pursuant to payment of IDCW, the NAV of the income distribution cum capital withdrawal 8 lnlerest service coverage ratio (times) 9.26 8.61 4.00 .8.92 l.94 4.54 options of the scheme would fall to the extent of payout and statutory levy (if applicablel. Notes: Such of the unitholders under me income distribution cum capital withdrawal opdons whose names appear in the 1. The above is an extract of the detailed fol!llat of unaudited Consolidated and Standalone Financial Results for the quarter and six months ended September register of urntholders as ar the close of business hours on the record date fixed for each income d1stnbut1on cum 30, 2026 filed w,th the Stock Exchanges under Regulation 33 and 52 of the SEBI (Listing Obligation,, and Disclosure Requirements) Regulations, 2015. cap,cal withdrawal shall be entltled to rece1Ve the Income distribution cum c [Showing first 8,000 characters — download PDF for full document]